Patent details

Basic Information

Publication number:

EP2956484

PCT Application Number:

IB2014000867

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147320063

PCT Publication Number:

WO2014125382

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CETUXIMAB WITH MODIFIED GLYCOSYLATION AND USES THEREOF

French Title of Invention:

CÉTUXIMAB AVEC GLYCOSYLATION MODIFIÉE ET UTILISATIONS ASSOCIÉES

German Title of Invention:

CETUXIMAB MIT MODIFIZIERTER GLYKOSILIERUNG UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

13/02/2014

Grant date:

14/11/2018

EP Publication Date:

23/12/2015

PCT Publication Date:

21/08/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/11/2018

EP B1 Publication Date:

14/11/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/02/2019

Expiration date:

13/02/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/11/2018

 

 

Name:

Laboratoire Français du Fractionnement et des Biotechnologies

Address:

3, Avenue des Tropiques ZA de Courtaboeuf, 91940 Les Ulis, France (FR)

Inventor

Name:

MEADE, Harry, M.

Address:

United States (US)

Priority

Priority Number:

201361764446 P

Priority Date:

13/02/2013

Priority Country:

United States (US)

Classification

IPC classification:

A01K 67/027; A61K 31/4745; A61K 31/513; A61K 31/522; A61K 39/00; A61K 39/395; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

201846

Publication date:

14/11/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages